Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IBO stock hub

Impact BioMedical Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IBOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

67.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

IBO

In the news

Latest news · IBO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-104.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-16.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IBO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001834105
Company name	Impact BioMedical Inc.
Country	United States
Country code	US
Cusip	45259L205
Employees	2
Employees Change	1%
Employees Change Percent	100
Enterprise value	$67.8M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-09-16
Isin	US45259L2051
Last refreshed	2026-05-10
Market cap	$67.8M
Market cap category	Micro-Cap
Price	$0.63
Price currency	USD
Rev Per Employee	16,000x
Sector	Healthcare
Sic	2834
Symbol	IBO
Website	https://www.impactbiomedinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.46%
EV/Sales	2,119.27x
FCF yield	-2.79%
P/B ratio	5.22x
P/S ratio	2,119.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-392,000
Net Income	$-11.8M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-45,156.25%
Profit Per Employee	$-5.9M
ROA	-14.16
Roa5y	-6.83
ROCE	-26.29
ROE	-104.2
Roe5y	-56.54
ROIC	-16.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	23.3%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x
Revenue Growth3 Y	-13.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$17.4M
Cash	$3,000
Current Assets	$411,000
Current Liabilities	$1.2M
Equity	$15.6M
Interest Coverage	-5.38
Liabilities	$1.9M
Long Term Assets	$17M
Long Term Liabilities	$688,000
Net Cash	$3,000
Net Cash By Market Cap	$0
Net Debt Equity	$-0
Tangible Book Value	$-4.4M
Tangible Book Value Per Share	$-0.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.35
Net Working Capital	$-754,000
Quick ratio	0.01
Working Capital	$-751,000
Working Capital Turnover	$-0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-193.3%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	23.29%
200-day SMA	0.56
50-day SMA	0.61
50-day SMA vs 200-day SMA	50over200
All Time High	6.17
All Time High Change	-89.81%
All Time High Date	2025-03-21
All Time Low	0.36
All Time Low Change	73.71%
All Time Low Date	2025-06-20
ATR	0.05
Beta1y	1.26
Beta2y	2.77
Ch YTD	24.55
High	0.64
High52	1.95
High52 Date	2025-06-23
High52ch	-67.74%
Low	0.61
Low52	0.36
Low52 Date	2025-06-20
Low52ch	73.71%
Ma50ch	3.66%
Premarket Change Percent	-0.99
Premarket Price	$0.62
Premarket Volume	1,706
Price vs 200-day SMA	12.2%
RSI	47.77
RSI Monthly	36.85
RSI Weekly	51.31
Sharpe ratio	0.79x
Sortino ratio	3.9
Total Return	-193.3%
Tr YTD	24.55
Tr1m	-6.04%
Tr1w	-4.26%
Tr3m	33.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-4.3M
Operating margin	-13,343.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,438,054%
Float Percent	10.61%
Net Borrowing	-109,000
Shares Insiders	2.83%
Shares Institutions	1.34%
Shares Out	107,821,231
Shares Qo Q	636.68%
Shares Yo Y	193.3%
Short Float	10.6%
Short Ratio	2.19
Short Shares	1.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-2.1M
Average Volume	81,570.95x
Bv Per Share	0.12
Ch1m	-6.04
Ch1w	-4.26
Ch1y	23.29
Ch3m	33.35
Ch6m	14.26
Change	0.3%
Change From Open	-0.21
Close	0.63
Days Gap	0.51
Depreciation Amortization	1,145,000
Dollar Volume	30,324.1
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-4.3M
EBITDA	$-3.1M
EPS	$-0.38
F Score	2
FCF	$-1.9M
FCF EV Yield	-2.79x
FCF Per Share	$-0.02
Financing CF	-109,000
Fiscal Year End	December
Founded	2,018
Income Tax	$-2.6M
Investing CF	3,000
Ipr	-79.03
Iprfo	-79.03
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	0.54
Ma150ch	16.68%
Ma20	0.66
Ma20ch	-4.54%
Net CF	-1,996,000
Next Earnings Date	2026-05-22
Open	0.63
Optionable	No
Position In Range	70.5
Pre Close	0.63
Price Date	2026-05-08
Relative Volume	0.59x
Revenue	32,000x
SBC By Revenue	634.38x
Share Based Comp	203,000
Tax By Revenue	-8,062.5x
Tr6m	14.26%
Us State	Texas
Volume	48,210
Z Score	0.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IBO pay a dividend?

Capital-return profile for this ticker.

Performance

IBO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IBO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.3%

Float: +10.6% of shares outstanding

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IBO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.8

Neutral momentum band

Price vs 200-day MA

+12.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IBO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IBO stock rating?

Impact BioMedical Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IBO analysis?

The full report lives at /stocks/IBO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IBO?

The latest report frames IBO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IBO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.